Bham Pharma

Our CEO Bilal Bham is living with Grave's Disease and Thyroid Eye Disease (TED). As a patient and pharma/biotech professional, he wants to help patients, and biotechs researching the space, with his knowledge and experiences 🧪 argenx is one of those biotechs researching TED. Shelley Gerson, their head of patient advocacy, kindly invited Bilal to their offices in Ghent, Belgium, and interviewed him in front of an audience of #argenx colleagues about his life experiences as a patient, and how he saw the research space evolving as a pharma professional 💬 We thank #argenx colleagues for their kindness, time, and generosity in making this possible, and for endeavouring to help patients like Bilal for whom surgery is currently the only approved option (in the UK via the NHS) 🙌🏾 #patientadvocacy #gravesdisease #thyroideyedisease #autoimmunedisease

Our CEO Bilal Bham is at Disneyland Paris for the WEConnect International Europe Supplier Diversity & Inclusion Conference! If you see him, please do go and chat to him 😊 #Diversity #Equity #Inclusion #SupplierDiversity #WeConnectInternational

Did you know that we are a registered diverse supplier? Our CEO Bilal Bham is in London over the next 2 days attending the MSDUK ESDP Business Diversity Conference, learning, and connecting with professionals from pharma and other industries, and fellow business owners! If you see him, do go say hi to him 🙌🏾

Real-world evidence (RWE) is transforming regulatory medical writing. For example, the FDA approved a new indication for Pfizer’s Ibrance (palbociclib) in combination with an aromatase inhibitor or fulvestrant to include men with certain types of metastatic breast cancer. In pharmacovigilance, it has become a mainstay to use routinely collected data about a patient’s health status or healthcare delivery from various sources other than traditional clinical trials to support decision-making. Have you seen the use of RWE in regulatory medical writing? If so, comment and let us know! #RegulatoryWriting #RealWorldEvidence #MedicalWriting #BhamPharma

📄 ***We are available for projects!*** 📄 #medicalwriter #medicalwriting #medicalcommunications #medcomms #BhamPharma

Bham Pharma's tips on writing better clinical trial protocols: ✒ To write better clinical trial protocols, focus on clarity, consistency, and compliance. ✒ Clearly define objectives, endpoints, and methodologies. Ensure alignment with regulatory guidelines and ethical standards. ✒ Include detailed instructions for the Investigators and consider patient safety at every step. Regularly review and update protocols based on emerging data and feedback. #BhamPharma #Regulatorymedicalwriting

Patient-reported outcomes (PRO) are reshaping regulatory writing. This approach ensures submissions reflect true patient experiences and treatment impacts. PRO measures have become crucial in evaluating clinical outcomes to assess the success of therapeutic interventions. Regulatory agencies agree that patients are the experts in understanding what it is like to live with their condition and what value can be assigned to their treatment. Recent refinements in data reporting have allowed rigorous interpretation of the results of these types of outcome measures. Careful understanding of PRO data interpretation is pivotal to applying these tools in regulatory decision-making. #BhamPharma #MedicalWriting

Thyroid Eye Disease (TED) is an autoimmune disease in which the eye muscles and fatty tissue behind the eye become inflamed causing the eyes to 'bulge'.   Learn about it in this comprehensive infographic! #thyroideyedisease #gravesdisease

Are you ready to take your pharma brand to new heights? 🌟 Effective communication is essential for standing out in the competitive market. That's where strategic medical communication comes into play! Here are some key strategies: Targeted Messaging: Develop personalised messages that resonate with specific healthcare professionals, patients, and stakeholders, ensuring relevance and engagement. Thought Leadership Content: Produce high-quality content that establishes the brand as an authoritative voice in its therapeutic area, fostering trust and credibility. Multichannel Approach: Implement a cohesive strategy across various communication channels, including digital platforms, conferences, publications, and key opinion leader (KOL) engagements, to maximise brand exposure. Brand Positioning: Define and reinforce the brand's unique value proposition through consistent messaging and positioning strategies, distinguishing it from competitors. Engagement Strategies: Foster meaningful interactions with stakeholders through interactive workshops, webinars, and educational initiatives, fostering brand loyalty and advocacy. Data-driven Insights: Utilise analytics and market research to gain actionable insights into audience preferences, behaviours, and trends, optimising communication strategies for maximum impact. Collaborative Partnerships: Forge strategic collaborations with KOLs, patient advocacy groups, and industry partners to amplify brand messaging and extend reach within target audiences. Measurable Outcomes: Establish clear objectives and key performance indicators (KPIs) to evaluate the effectiveness of communication efforts, enabling continuous improvement and refinement of strategies for ongoing brand elevation. Ready to elevate your pharma brand with strategic medical communication? Let's connect and explore how we can help you achieve your goals! Contact us at www.bhampharma.com for more information. #PharmaMarketing #MedicalCommunication #BrandElevation

It's no longer sufficient to solely focus on the pill itself. We're entering an era where communication must transcend traditional boundaries, spotlighting the value embedded within pharma solutions. At Bham Pharma, we're not just about selling a service; we're about creating narratives that resonate deeply, driving understanding, trust, and ultimately, action. Our approach goes beyond the pill, spotlighting comprehensive benefits. We probe into the broader impact of pharma solutions, emphasising improved patient outcomes, healthcare efficiencies, and societal advancements. We captivate audiences with advance communication strategies. Through captivating narratives, and engaging visuals, we ensure your message resonates and inspires action, driving meaningful engagement with your brand. Customising messages for global impact, respecting local regulations and cultures. With a deep understanding of international markets, we adapt communication strategies to align with diverse regulatory environments, cultural nuances, and language preferences, ensuring maximum impact and resonance. Empowering healthcare professionals to endorse and prescribe with confidence. We equip HCPs with comprehensive knowledge and resources, enabling them to make informed decisions about your products and confidently advocate for them, ultimately driving uptake and patient adherence. 🤝Let's collaborate to amplify your brand's voice, inspiring audiences to see the bigger picture and embrace the value that lies #BeyondThePill. Together, we'll navigate the evolving healthcare sector, driving meaningful change and improving lives. Contact us at www.bhampharma.com for more information. #PharmaCommunication #MedicalInnovation #ValueBasedCare #HealthcareMessaging